The value of a clinical trial management system (CTMS) is much more than its current functionality; it’s how the system addresses the changing needs of clinical research institutions by continuously providing solutions to everyday operational challenges as well as evolving industry requirements. When a system no longer meets the needs of an institution, a fresh approach must be taken.
Many leading clinical research institutions have addressed this call-to-action by moving to a new CTMS that meets the evolving needs of their research enterprises. Below, three institutions share their experiences of switching to Forte Research System’s OnCore Enterprise Research.
Switching to a new system
The Mary Babb Randolph Cancer Center at West Virginia University found it was using a CTMS that required a large amount of custom programming to obtain and use necessary information. As the center began to take in larger volumes of clinical trials and sought to gain NCI designation, the need for a new system with a wider range of functionality became more apparent.
The center chose OnCore Enterprise Research to meet their changing goals due to the system’s focus on innovation. Since implementing OnCore, the center has found benefits associated with more robust built-in functionality, including more reporting capabilities.
The motivation to change systems at University of Florida Shands Cancer Center derived from the growing need to connect with partnering cancer centers to conduct clinical trial operations and integrate with internal systems. The center found its current system was not providing the integration functionality necessary to work with other cancer centers in an effective capacity.
Flexibility and collaboration was a key consideration when deciding on a vendor and CTMS to support the center’s evolving needs. After implementing OnCore, the center is now able to integrate with both internal systems and partner institutions, improving operational efficiency and facilitating more effective multi-institutional research.
For the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, there was a clear need for a comprehensive CTMS that could improve and expedite performance of the center’s complex clinical research environment. Following a wide-ranging assessment of the center’s operational needs and goals, OnCore stood out as a system that could handle operations throughout a study’s life-cycle.
While the goals of these separate institutions varied, the resounding similarity between the three experiences was the need for a CTMS that evolves to keep pace with the changing goals and operational requirements of each institution.
Read the full story
To learn more about how these three institutions selected and implemented OnCore Enterprise Research for their clinical research operations, read the full case study, “Switching to a New Enterprise Research System.”
This article was originally published in October 2012.